07/02/2019 - 11:10

PharmAust to start canine cancer drug trials this month

07/02/2019 - 11:10

Bookmark

Save articles for future reference.

PharmAust has executed an agreement with a major US contract research organisation to start Phase I clinical trials for its flagship anti-cancer drug Monepantel in dogs on 19 February 2019 using its final tablet format. This will provide information on the number of tablets, administration frequency, blood levels and verification of safety for the Phase II trials in pet owners’ dogs with naturally occurring cancers.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options